CRL vs ONC
Charles River Laboratories vs BeOne Medicines AG — AI-powered side-by-side comparison
CRL
Charles River Laboratories
61
Buy
VS
ONC
BeOne Medicines AG
67
Buy
| Metric | CRL | ONC |
|---|
| AI Score |
61
|
67
|
| Price |
$297.55
|
$376.87
|
| P/E Ratio |
-61.69×
|
27.33×
|
| ROE |
-4.6%
|
6.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
32.2%
|
87.8%
|
| Debt / Equity |
1.07×
|
0.22×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
79.8
|
67.1
|
| Beta |
1.376
|
0.5
|
| Expected Upside |
+1.4%
|
+0.2%
|
AI Committee View
Current Innellis committee reasoning for CRL versus ONC.
ONC leads by 6 points.
ONC scores 67/100 (Buy) versus CRL at 61/100 (Buy).
CRL Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 35.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- RSI at 80 is in overbought territory — Technical
- Weekly RSI at 87 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 35.8% signals elevated volatility — Risk
ONC Committee View
83% agreement
6 analysts
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+1.00 across 1 articles, 14d). Value Analyst remains cautious — p/e of 88.1 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 36.2% YoY -- genuine top-line momentum — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 88.1 is expensive by classic value standards — Value
- Price-to-book of 8.7x prices in significant intangible value — Value
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical